CD44 and gastric cancer: Verteporfin effect inhibited Y/T-TEAD transcriptional activity, cell proliferation and CD44 expression, reduced the pool of tumor-forming CD44+/aldehyde dehydrogenase (ALDH)-high gastric CSCs, and inhibited GC tumor growth in vivo (Giraud et al., 2020) (Figures 4B,C).